- Headquarters
- Zurich
- Business Model
- B2B
- Website
- centenara.com
- Total Funding
- $75.0M
- Last Round
- $75.0M Series BSep 2023
- Rounds
- 1
About
Centenara Labs AG, formerly known as Rejuveron Life Sciences AG, is a Zurich-based biotechnology company focused on pioneering therapies to promote healthy aging. The company has reported encouraging preliminary clinical results on a novel blindness treatment, EA-2353, for Retinitis Pigmentosa. Centenara's rebrand positions the business for strategic initiatives designed to support development of therapies for regenerative medicine and age-related disorders.
Summary
Centenara Labs is a Biotech company based in Zurich, Switzerland. It has raised $75.0M in total across 1 round, most recently a $75.0M Series B round in Sep 2023. Investors include Apeiron Investment Gro.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2023
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/centenara-labs"><img src="https://indexed.vc/api/badge/company/centenara-labs" alt="Centenara Labs on Indexed.vc" width="260" height="76" /></a>